- 全部删除
您的购物车当前为空
GNE-900 是一种 ATP 竞争性、选择性和口服活性 ChK1抑制剂,对 ChKl,ChK2的 IC50值分别为为 0.0011,1.5 µM。GNE-900 废除 G2-M 检查点,增强 DNA 损伤,并诱导胞凋亡 (Apoptosis)。gemcitabine 和 GNE-900 给药显示抗肿瘤活性[1]< /sup>。


为众多的药物研发团队赋能,
让新药发现更简单!
GNE-900 是一种 ATP 竞争性、选择性和口服活性 ChK1抑制剂,对 ChKl,ChK2的 IC50值分别为为 0.0011,1.5 µM。GNE-900 废除 G2-M 检查点,增强 DNA 损伤,并诱导胞凋亡 (Apoptosis)。gemcitabine 和 GNE-900 给药显示抗肿瘤活性[1]< /sup>。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 401 | In stock | |
| 5 mg | ¥ 966 | In stock | |
| 10 mg | ¥ 1,570 | In stock | |
| 25 mg | ¥ 2,770 | In stock | |
| 50 mg | ¥ 4,170 | In stock | |
| 100 mg | ¥ 5,730 | In stock | |
| 200 mg | ¥ 7,680 | In stock |
GNE-900 相关产品
| 产品描述 | GNE-900 is an ATP-competitive ChK1 inhibitor with selective and oral activity.GNE-900 inhibits ChKl and ChK2 with IC50 values of 0.0011 and 1.5 µM, respectively.GNE-900 enhances DNA damage and induces apoptosis. GNE-900 has antitumor activity. |
| 靶点活性 | Chk1:0.0011 μM, Chk2:1.5 μM |
| 别名 | GNE900, GNE 900 |
| 分子量 | 367.45 |
| 分子式 | C23H21N5 |
| CAS No. | 1200126-26-6 |
| Smiles | C(#N)C=1C=C2C=3C(NC2=CN1)=NC=C(C3)C4=CC=C(CN5CCCCC5)C=C4 |
| 存储 | store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| 溶解度信息 | DMSO: 3.85 mg/mL (10.47 mM), Sonication is recommended. | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
评论内容